Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This study observed that topically applied 2% minoxidil solution significantly increased hair counts in men with early male pattern alopecia over 24 weeks, with no serious safety concerns.

This study found that preserving hair follicles at 4℃ using Ringer's solution during FUE Megasession hair transplantation surgery significantly improves cell survival rates and supports optimal hair growth, demonstrating clinical feasibility for longer procedures.

This study found that a positive family history, especially from the mother's side and including grandparents, is associated with an increased risk of early-onset female pattern hair loss in Polish women.

This retrospective cohort study found that both spironolactone and bicalutamide significantly improved Sinclair grade in women with female pattern hair loss over 24 months, but spironolactone, especially at doses above 100 mg/day, resulted in greater efficacy, required less monitoring, and maintained comparable safety.

This study found that serum 3α-androstanediol glucuronide levels were higher in Indian women with female pattern hair loss and correlated with the severity of the condition.

This study established consensus-based guidelines for using low-dose oral and topical minoxidil in managing pattern hair loss for patients undergoing hair transplant surgery, recommending specific dosages, monitoring procedures, and timing for initiation post-surgery.

This study found that oral spironolactone 100 mg daily for 24 weeks improved terminal hair counts and diameters in premenopausal women with female pattern hair loss when used alongside minoxidil, despite a higher incidence of menstrual irregularities.

This study analyzed global research on female pattern hair loss from 1957 to 2024, reporting trends in publication output and hotspots in topics like treatment mechanisms and safety, with the USA leading in contributions and citations.

This study found that growth factor concentrate provides quicker improvements for patterned hair loss, but platelet-rich plasma offers more sustained benefits after treatment.

In this study, a holistic hair treatment regimen significantly increased hair density in men with stages 2-4 male androgenetic alopecia, showing a more effective outcome than minoxidil over six months, and offering an alternative to traditional treatments.

Systemic minoxidil improves hair density in women with female pattern hair loss over time.

This study observed a high prevalence of noninfectious skin disorders among orphaned children in Egyptian orphanages, linked significantly to hygiene conditions and highlighting the need for comprehensive care strategies.

In this study, researchers identified three novel genetic loci associated with androgenetic alopecia, including one with significant association in females only, which may indicate a role for sex-specific genetic factors in patterned hair loss.

This study found that male pattern baldness was most common among Bangladeshi alopecia patients and reported good treatment efficacy in nearly half of the cases, but chronic diseases, stress, oily hair, and smoking were negatively associated with treatment outcomes.

This study investigated dermatological conditions among 223 Indian postmenopausal women, reporting that 83.4% had skin disorders, 29.1% had genital symptoms, 10.3% had oral issues, 33.6% experienced hair disorders, and 26% faced nail problems.

This study found that males with a maternal history of androgenetic alopecia were significantly more likely to have female pattern hair loss, suggesting early screening might be beneficial.

In this survey of dermatologists in India, most participants reported that nutritional deficiencies are common in alopecia patients and preferred using serum peptide formulations, rating them as "very good" or "good" for efficacy, with Folliserum receiving high marks for aesthetics.

This study found that thymosin β4 is highly expressed in multiple human tissues and may play a role in organ function and angiogenesis through co-localization with VEGF.

This study reports that children receive only 46.5% of recommended health care services.

This study found that a topical 1.0% sildenafil citrate solution significantly increased vellus and terminal hairs in women with female pattern hair loss without affecting hair thickness, suggesting it may be a promising treatment option.

Mutations in the WNT10A gene cause Short Anagen Hair syndrome and increase the risk of male pattern hair loss.

This study observed that Taiwanese men aged 40–91 who smoked 20 or more cigarettes daily had a higher incidence of moderate to severe androgenetic alopecia.

This study found that premenopausal women with female-pattern hair loss had significantly lower serum vitamin D levels compared to healthy controls, suggesting a potential role of vitamin D deficiency in this condition.

In this study, researchers found that trichoscopy helps detect early signs of female-pattern hair loss before it is visible, highlighting its importance for monitoring and managing the condition.

This study found that combining topical minoxidil with oral spironolactone improved hair loss outcomes in women with female pattern hair loss when compared to minoxidil alone, but benefits plateaued after 6 months.

This study found that using a combination of 10% topical minoxidil, oral finasteride, and microneedling for six months effectively improved male pattern baldness with moderate to excellent responses and high patient satisfaction, without major side effects among the 25 participants.

This study provided a dynamic 4D atlas showing the development process of mouse hair follicles through a telescope-like model, revealing new insights into the origin of hair follicle stem cells.

This study found that minoxidil increased 17ß-hydroxysteroid dehydrogenase activity by nearly 40% in dermal papilla cells from balding scalps but not in nonbalding scalp cells or dermal fibroblasts.

Male pattern baldness is largely genetic, linked to the androgen receptor gene, and may relate to certain health issues.

This article discusses the evaluation and management of a 45-year-old woman with diffuse scalp-hair loss and reports no new clinical findings.